Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H25N3O3 |
| Molecular Weight | 367.4415 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)NC1=CC=C2CCC3=C(C=CC=C3)N(C(=O)CN(C)C)C2=C1
InChI
InChIKey=KJAMZCVTJDTESW-UHFFFAOYSA-N
InChI=1S/C21H25N3O3/c1-4-27-21(26)22-17-12-11-16-10-9-15-7-5-6-8-18(15)24(19(16)13-17)20(25)14-23(2)3/h5-8,11-13H,4,9-10,14H2,1-3H3,(H,22,26)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination]. | 1998-06 |
|
| [The anti-arrhythmia action of tiracizine in patients with ischemic heart disease and decreased myocardial contractile function]. | 1997-06 |
|
| Day-night variations in the renal excretion of the antiarrhythmic agent tiracizine and its metabolites. | 1995-04 |
|
| Use dependent depression of fast sodium current in heart muscle by the new antiarrhythmic substance Bonnecor (AWD 19-166, GS 015). | 1985-12 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8653799
7-day multiple-dose study period (50 mg tiracizine twice daily)
Route of Administration:
Oral
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QC01EB11
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
||
|
WHO-ATC |
C01EB11
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
||
|
NCI_THESAURUS |
C47793
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9UUO2T61K7
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
2679
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
CHEMBL1625260
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
C048166
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
6494
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
83275-56-3
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
DB13635
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
DTXSID5048714
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
TIRACIZINE
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
71264
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
C75137
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
SUB11114MIG
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY | |||
|
100000077265
Created by
admin on Wed Apr 02 08:59:16 GMT 2025 , Edited by admin on Wed Apr 02 08:59:16 GMT 2025
|
PRIMARY |
ACTIVE MOIETY